Skip to content
The San Antonio

FDA adds rare vision-loss warning to popular GLP-1 drugs

FDA adds rare vision-loss warning to popular GLP-1 drugs
Photo: KSAT 12 (ABC affiliate) · view original

Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday. The Food and Drug Administration said the risk will be added to the labeling of all GLP-1 dr...

Sources and story details